We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$355M
Cap. Flow
+$316M
Cap. Flow %
26.21%
Top 10 Hldgs %
40.06%
Holding
747
New
182
Increased
169
Reduced
181
Closed
163

Sector Composition

Rank Sector Weight
1 Healthcare 36.03%
2 Financials 28.77%
3 Technology 9.99%
4 Energy 5.75%
5 Consumer Discretionary 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVLVW
201
DELISTED
Evolv Technologies Warrant
EVLVW
$268K 0.02%
+195,600
New +$189K
AAIC
202
DELISTED
Arlington Asset Investment Corp.
AAIC
$263K 0.02%
+56,717
New +$185K
ABLLW
203
DELISTED
Abacus Life Warrant
ABLLW
$251K 0.02%
914,836
-97,139
-10% -$19.2K
TMTCU
204
DELISTED
TMT Acquisition Corp Unit
TMTCU
$243K 0.02%
23,200
-142,179
-86% -$1.48M
TBMC
205
DELISTED
Trailblazer Merger Corp I
TBMC
$238K 0.02%
+23,404
New +$237K
CANO.WS
206
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$224K 0.02%
1,067,655
+446,574
+72% +$112K
PSQH icon
207
PSQ Holdings
PSQH
$14.6M
$224K 0.02%
1,452
-4,618
-76% -$704K
BAK icon
208
Braskem
BAK
$917M
$218K 0.02%
+18,744
New +$177K
RENE
209
DELISTED
Cartesian Growth Corp II
RENE
$210K 0.02%
+19,681
New +$208K
CDAQ
210
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
$208K 0.02%
+20,123
New +$207K
LCAAW
211
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$208K 0.02%
424,302
-374,072
-47% -$185K
GSRMR
212
DELISTED
GSR II Meteora Acquisition Corp. Right
GSRMR
$207K 0.02%
65,778
+26,216
+66% +$40K
NRAC
213
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$204K 0.02%
+19,400
New +$201K
CCAI
214
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
$203K 0.02%
18,445
-6,555
-26% -$69.3K
DECA
215
DELISTED
Denali Capital Acquisition Corp. Class A Ordinary Shares
DECA
$202K 0.02%
+18,814
New +$200K
TALKW
216
DELISTED
Talkspace Inc Warrant
TALKW
$200K 0.02%
3,328,553
-656,201
-16% -$47.8K
GLST
217
DELISTED
Global Star Acquisition, Inc. Class A Common Stock
GLST
$200K 0.02%
+19,057
New +$198K
KITTW icon
218
Nauticus Robotics Warrant
KITTW
$198K
$197K 0.02%
886,075
+134,979
+18% +$29.3K
HUDA
219
DELISTED
Hudson Acquisition I Corp. Common Stock
HUDA
$197K 0.02%
+19,042
New +$196K
CPUH.WS
220
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$197K 0.02%
393,827
+303,402
+336% +$113K
NETC
221
DELISTED
Nabors Energy Transition Corp.
NETC
$196K 0.02%
18,400
-148
-0.8% -$1.56K
LOCC
222
DELISTED
Live Oak Crestview Climate Acquisition Corp.
LOCC
$192K 0.02%
+18,701
New +$190K
AILEW
223
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$182K 0.02%
727,730
+676,979
+1,334% +$124K
HLLY.WS
224
DELISTED
Holley Inc Warrants
HLLY.WS
$175K 0.01%
349,744
+83,861
+32% +$30.2K
GSAT icon
225
Globalstar
GSAT
$10.9B
$174K 0.01%
10,733
+9,400
+705% +$151K

Similar funds

Cowen and Company's Q2 2023 Portfolio in Review

As of Q2 2023, Cowen and Company held 747 positions worth $1.21B, up 42% from $851M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cowen and Company deployed $316M of net new capital in Q2 2023, opening 182 new positions and adding to 169 existing holdings. Its largest new stake was NVIDIA: 1,927,500 shares worth $81.5M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Avadel Pharmaceuticals, an estimated $13.9M trimmed.

  • Cowen and Company's largest Q2 2023 buy was NVIDIA: 1,927,500 shares worth $81.5M.
  • Cowen and Company added most to Ares Acquisition Corporation in Q2 2023, an estimated $15.9M increase.
  • Cowen and Company's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $13.9M.
  • Cowen and Company fully exited Sylvamo in Q2 2023, selling an estimated $99.5M.
  • Cowen and Company's ten largest holdings make up 40% of its $1.21B portfolio in Q2 2023.
  • Cowen and Company opened 182 new positions and closed 163 in Q2 2023.
  • Cowen and Company's portfolio value rose 42% quarter-over-quarter to $1.21B.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.